Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoko Tadokoro

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
Clinical and Translational Science|March 5, 2025
Transarterial Chemoembolization for Patients With Hepatocellular Carcinoma Using Miriplatin Without the Need for HydrationKoji Fujita, Kei Takuma, Kyoko Oura, et al.
International Journal of Molecular Sciences|September 13, 2025
Genetic Polymorphisms of <i>ALDH2</i> and <i>ADH1B</i> in Alcohol-Induced Liver Injury: Molecular Mechanisms of Inflammation and Disease Progression in East Asian PopulationsTomoko Tadokoro, Kyoko Oura, Mai Nakahara, et al.
Cancers|September 27, 2025
Chronic Liver Disease Associated Cholangiocarcinoma: Genomic Insights and Precision Therapeutic StrategiesKyoko Oura, Asahiro Morishita, Mai Nakahara, et al.
International Journal of Molecular Sciences|April 13, 2023
Galectin-9 in Gastroenterological CancerAsahiro Morishita, Kyoko Oura, Tomoko Tadokoro, et al.
Internal Medicine (Tokyo, Japan)|December 28, 2017
Severe Steroid-responsive Skin Disorders Related to Ledipasvir and Sofosbuvir for HCVTomoko Tadokoro, Asahiro Morishita, Koji Fujita, et al.
International Journal of Molecular Sciences|October 14, 2023
MicroRNAs and Nonalcoholic Steatohepatitis: A ReviewAsahiro Morishita, Kyoko Oura, Tomoko Tadokoro, et al.
Internal Medicine (Tokyo, Japan)|November 30, 2022
Ledipasvir/Sofosbuvir Is Effective for Relapsed Genotype 1b Hepatitis C Virus Patients after Achieving a Sustained Virological Response at Post-treatment Week 12 with Glecaprevir/PibrentasvirTakushi Manabe, Tomoko Tadokoro, Mai Nakahara, et al.
International Journal of Molecular Sciences|January 25, 2025
Galectins and Liver DiseasesShima Mimura, Asahiro Morishita, Kyoko Oura, et al.
Internal and Emergency Medicine|March 30, 2021
Prognosis of probable autoimmune hepatitis patients: a single-center study in JapanKoji Fujita, Kyoko Oura, Tomoko Tadokoro, et al.
Molecular and Clinical Oncology|June 28, 2021
Multimodal treatment involving molecular targeted agents and on-demand transcatheter arterial chemoembolization for advanced hepatocellular carcinoma: A case report and review of the literatureKyoko Oura, Kei Takuma, Mai Nakahara, et al.
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Clinical and Translational Science|March 5, 2025
Transarterial Chemoembolization for Patients With Hepatocellular Carcinoma Using Miriplatin Without the Need for HydrationKoji Fujita, Kei Takuma, Kyoko Oura, et al.
International Journal of Molecular Sciences|September 13, 2025
Genetic Polymorphisms of <i>ALDH2</i> and <i>ADH1B</i> in Alcohol-Induced Liver Injury: Molecular Mechanisms of Inflammation and Disease Progression in East Asian PopulationsTomoko Tadokoro, Kyoko Oura, Mai Nakahara, et al.
Cancers|September 27, 2025
Chronic Liver Disease Associated Cholangiocarcinoma: Genomic Insights and Precision Therapeutic StrategiesKyoko Oura, Asahiro Morishita, Mai Nakahara, et al.
International Journal of Molecular Sciences|April 13, 2023
Galectin-9 in Gastroenterological CancerAsahiro Morishita, Kyoko Oura, Tomoko Tadokoro, et al.
Internal Medicine (Tokyo, Japan)|December 28, 2017
Severe Steroid-responsive Skin Disorders Related to Ledipasvir and Sofosbuvir for HCVTomoko Tadokoro, Asahiro Morishita, Koji Fujita, et al.
International Journal of Molecular Sciences|October 14, 2023
MicroRNAs and Nonalcoholic Steatohepatitis: A ReviewAsahiro Morishita, Kyoko Oura, Tomoko Tadokoro, et al.
Internal Medicine (Tokyo, Japan)|November 30, 2022
Ledipasvir/Sofosbuvir Is Effective for Relapsed Genotype 1b Hepatitis C Virus Patients after Achieving a Sustained Virological Response at Post-treatment Week 12 with Glecaprevir/PibrentasvirTakushi Manabe, Tomoko Tadokoro, Mai Nakahara, et al.
International Journal of Molecular Sciences|January 25, 2025
Galectins and Liver DiseasesShima Mimura, Asahiro Morishita, Kyoko Oura, et al.
Internal and Emergency Medicine|March 30, 2021
Prognosis of probable autoimmune hepatitis patients: a single-center study in JapanKoji Fujita, Kyoko Oura, Tomoko Tadokoro, et al.
Molecular and Clinical Oncology|June 28, 2021
Multimodal treatment involving molecular targeted agents and on-demand transcatheter arterial chemoembolization for advanced hepatocellular carcinoma: A case report and review of the literatureKyoko Oura, Kei Takuma, Mai Nakahara, et al.
Pageof 10